Found: 16
Select item for more details and to access through your institution.
A Hyperfluorinated Hydrophilic Molecule for Aqueous <sup>19</sup>F MRI Contrast Media.
- Published in:
- Contrast Media & Molecular Imaging, 2018, p. 1, doi. 10.1155/2018/1693513
- By:
- Publication type:
- Article
Molecular MRI Identifies Sexually Dimorphic AD Pathology in 3x Tg‐AD Mice.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077269
- By:
- Publication type:
- Article
MRI of Neuroinflammation Using a Folate Receptor β‐Targeted Nanoparticle Contrast Agent.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.073739
- By:
- Publication type:
- Article
MR Nano‐Radiomics for Detection of Amyloid Plaques in Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.062917
- By:
- Publication type:
- Article
Plasma pTau markers correlate with an imaging surrogate marker of hyperphosphorylation in mouse models of Alzheimers disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.069466
- By:
- Publication type:
- Article
MRI visualization of activated monocytes accumulation in the CNS of P301S tau mice by targeted nanoparticle technology: An approach to MRI molecular imaging of neuroinflammation: Molecular and cell biology/neuroinflammation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045473
- By:
- Publication type:
- Article
A novel MRI contrast agent for identifying hyperphosphorylative neurons as a marker of future tau pathology: Neuroimaging: Novel imaging methods.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041080
- By:
- Publication type:
- Article
Pre‐clinical dose ranging efficacy testing of ADx: A contrast agent for magnetic resonance imaging of amyloid burden in Alzheimer's disease: Neuroimaging: Novel imaging methods.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.039541
- By:
- Publication type:
- Article
1‐Indanone and 1,3‐indandione Derivatives as Ligands for Misfolded α‐Synuclein Aggregates.
- Published in:
- ChemMedChem, 2022, v. 17, n. 2, p. 1, doi. 10.1002/cmdc.202100611
- By:
- Publication type:
- Article
Intravenous Delivery of Targeted Liposomes to Amyloid-β Pathology in APP/PSEN1 Transgenic Mice.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0048515
- By:
- Publication type:
- Article
Non Inflammatory Boronate Based Glucose-Responsive Insulin Delivery Systems.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0029585
- By:
- Publication type:
- Article
Cerebral vascular leak in a mouse model of amyloid neuropathology.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2014, v. 34, n. 10, p. 1646, doi. 10.1038/jcbfm.2014.125
- By:
- Publication type:
- Article
Rational Design of a Self‐Assembling High Performance Organic Nanofluorophore for Intraoperative NIR‐II Image‐Guided Tumor Resection of Oral Cancer.
- Published in:
- Advanced Science, 2023, v. 10, n. 10, p. 1, doi. 10.1002/advs.202206435
- By:
- Publication type:
- Article
Advances in nanoprobes for molecular MRI of Alzheimer's disease.
- Published in:
- WIREs: Nanomedicine & Nanobiotechnology, 2024, v. 16, n. 2, p. 1, doi. 10.1002/wnan.1946
- By:
- Publication type:
- Article
A surrogate marker for very early-stage tau pathology is detectable by molecular magnetic resonance imaging.
- Published in:
- Theranostics, 2022, v. 12, n. 12, p. 5504, doi. 10.7150/thno.72258
- By:
- Publication type:
- Article
A dual target molecular magnetic resonance imaging probe for noninvasive profiling of pathologic alpha-synuclein and microgliosis in a mouse model of Parkinson’s disease.
- Published in:
- Frontiers in Neuroscience, 2024, p. 1, doi. 10.3389/fnins.2024.1428736
- By:
- Publication type:
- Article